Advertisement
UK markets open in 1 hour 16 minutes

  • NIKKEI 225

    37,652.55
    -807.53 (-2.10%)
     

  • HANG SENG

    17,259.82
    +58.55 (+0.34%)
     

  • CRUDE OIL

    82.94
    +0.13 (+0.16%)
     

  • GOLD FUTURES

    2,329.30
    -9.10 (-0.39%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,524.66
    -1,986.45 (-3.71%)
     

  • CMC Crypto 200

    1,385.74
    -38.36 (-2.69%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

Atara Biotherapeutics: 1Q Earnings Snapshot

Atara Biotherapeutics: 1Q Earnings Snapshot

Associated Press

SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Thursday reported a loss of $66.3 million in its first quarter.

The South San Francisco, California-based company said it had a loss of $1.44 per share.

The results exceeded Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.48 per share.

Atara Biotherapeutics shares have decreased slightly more than 1% since the beginning of the year. The stock has declined 13% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA